Updates in Management of Hypertensive Disorders of Pregnancy
Hypertensive disorders of pregnancy (HDP) were discovered a long time
ago but our knowledge about their etiopathogenesis are still limited.
These disorders can affect many pregnant women all over the world
putting them, their families and their countries under significant
health burden.
The main goal of all research efforts regarding treatment of HDP is how
to prevent highly morbid complications and mortality of HDP that may
affect both mother and fetus. Delivery is the main line of treatment for
severe cases, but we have to put in our mind risk of prematurity as a
possible outcome in case of termination besides the possibility of
incidence of complications like eclampsia and hypertensive emergency
postnatally.
Researchers believed that studies working on prevention would result in
major improvement of overall women care worldwide, and screening
will definitely allow prompt starting therapy for those patients and
prevent further sequences. Recently many guidelines support and
recommend
Aspirin 81mg for the prevention of preeclampsia in high-risk patients
using evidence-based data about the time and indications of its intake.
Great
efforts have been contributed to developing evidence-based guidelines to
enhance our strategies to deal with these disorders. Reviewing, pooling
and comparing these guidelines would help us to refine our questions
that may need to be answered by further studies. Trials confirmed that
application of standardized strategies for treating HDP significantly
improves both maternal and fetal outcomes. In this article, we are going
to
review recent updates and guidelines about the treatment of HDP and
provide references for your further readings.
For More Open Access Journals in Iris Publishers Please click on:
https://irispublishers.com/
For More Articles in World Journal of Gynecology & Womens Health
https://irispublishers.com/wjgwh/
https://irispublishers.com/
For More Articles in World Journal of Gynecology & Womens Health
https://irispublishers.com/wjgwh/

No comments:
Post a Comment